Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Overweight Jordanian Women with PCOS
NCT02328404Phase 3Completed
- Sponsor
- Hayat Pharmaceutical Industries Co. PLC
- Start
- Feb 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in polycystic ovary syndrome (PCOS) and vitamin D deficiency comparing vitamin D3 (Biodal 50,000 IU) with placebo (2 arms). Primary endpoints: Ultrasound Examination of Number of Follicles and Ovarian Volume at 3 months, Menstrual Regularity at 3 months and 5 more. Started Feb 2014; status: completed.
02
Drugs
cholecalciferol
03
Conditions
polycystic ovary syndrome (PCOS)vitamin D deficiency
Beyond the preview
Go deeper on NCT02328404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02328404.